Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 HKD | +1.59% | +4.92% | +4.92% |
Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
Feb. 29 | Yixin Group Logs 50% Rise in Fiscal 2023 Profit | MT |
Sales 2024 * | 7.64B 1.05B 8.26B | Sales 2025 * | 8.39B 1.16B 9.07B | Capitalization | 3.86B 533M 4.17B |
---|---|---|---|---|---|
Net income 2024 * | 684M 94.42M 739M | Net income 2025 * | 819M 113M 885M | EV / Sales 2024 * | 0.51 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.46 x |
P/E ratio 2024 * |
5.8
x | P/E ratio 2025 * |
4.85
x | Employees | 4,231 |
Yield 2024 * |
5.24% | Yield 2025 * |
6.25% | Free-Float | 20.71% |
Latest transcript on Yixin Group Limited
1 day | +1.59% | ||
1 week | +4.92% | ||
Current month | -3.03% | ||
1 month | -5.88% | ||
3 months | +25.49% | ||
6 months | +1.59% | ||
Current year | +4.92% |
Managers | Title | Age | Since |
---|---|---|---|
Xuan Zhang
CEO | Chief Executive Officer | 49 | 13-11-30 |
Gao Zhi
PSD | President | 53 | 16-08-31 |
Xiao Guang Yang
DFI | Director of Finance/CFO | 49 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tin Fan Yuen
BRD | Director/Board Member | 70 | 17-11-05 |
Lily Li Dong
BRD | Director/Board Member | 54 | 17-05-31 |
Xuan Zhang
CEO | Chief Executive Officer | 49 | 13-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.64 | +1.59% | 4 035 000 |
24-04-24 | 0.63 | +1.61% | 4,329,500 |
24-04-23 | 0.62 | 0.00% | 1,778,000 |
24-04-22 | 0.62 | +3.33% | 2,137,000 |
24-04-19 | 0.6 | -4.76% | 3,603,500 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.92% | 525M | |
+1.11% | 2.6B | |
+10.08% | 2.13B | |
-4.11% | 1.15B | |
+13.47% | 770M | |
-.--% | 314M | |
-8.70% | 279M | |
+3.65% | 242M | |
+30.37% | 188M | |
+3.14% | 184M |
- Stock Market
- Equities
- 2858 Stock